Archives
-
Evaluating Low-Cost Microfluidic Mixers for LNP-mRNA Manufac
2026-05-06
Forrester et al. (2025) systematically assessed whether low-cost microfluidic mixers can reliably produce lipid nanoparticles (LNPs) suitable for mRNA delivery, comparing them to manual pipette mixing. Their findings show that inexpensive microfluidic approaches retain high encapsulation efficiency and produce LNPs with consistent expression profiles, supporting broader accessibility for high-throughput mRNA formulation research.
-
Nilotinib (AMN-107) for Precision BCR-ABL Signaling Research
2026-05-05
Nilotinib (AMN-107) stands out as a precision tool for dissecting BCR-ABL and KIT-driven signaling in both chronic myeloid leukemia and gastrointestinal stromal tumor models. Its robust selectivity profile and nanomolar potency enable reproducible, data-rich experiments that advance translational kinase pathway research.
-
RP3-340N1.2 Knockdown Destabilizes IL-6 and Inhibits NSCLC P
2026-05-05
This study demonstrates that the long non-coding RNA RP3-340N1.2 promotes non-small cell lung cancer (NSCLC) progression by stabilizing IL-6 mRNA. Functional knockdown of RP3-340N1.2 enhances IL-6 mRNA degradation, suppressing tumor proliferation and migration, and highlighting a novel axis for targeted research in transcriptional regulation and tumor microenvironment interactions.
-
TRIM66 Controls Monogenic Olfactory Receptor Expression in O
2026-05-04
This study identifies TRIM66 as an essential epigenetic repressor governing the singular expression of olfactory receptor genes in sensory neurons. By resolving the molecular basis behind the 'one neuron, one receptor' rule, the work advances understanding of sensory gene regulation and offers methodological insights relevant to epigenetics and transcriptional control.
-
Firefly Luciferase mRNA (5-moUTP): Workflow, Assay, and Opti
2026-05-04
EZ Cap™ Firefly Luciferase mRNA (5-moUTP) from APExBIO delivers robust, low-immunogenicity reporter expression for gene regulation and translation efficiency assays. This guide bridges bench workflows and the latest delivery innovations to maximize reproducibility and protein yield.
-
Cy5 TSA Fluorescence System Kit: Precision Signal Amplificat
2026-05-03
The Cy5 TSA Fluorescence System Kit enables 100-fold sensitivity enhancement for immunohistochemistry and in situ hybridization through horseradish peroxidase catalyzed tyramide deposition. This workflow reduces primary antibody use and enables detection of low-abundance targets, ensuring high specificity and rapid turnaround. APExBIO's K1052 kit is validated for robust, reproducible fluorescence labeling.
-
EZ Cap™ Firefly Luciferase mRNA: Cap 1 Reporter for Reliable
2026-05-02
EZ Cap™ Firefly Luciferase mRNA is a Cap 1-structured, in vitro-transcribed reporter for robust gene regulation assays and in vivo imaging. Its optimized capping and poly(A) tail ensure superior stability and translation efficiency, supporting high-sensitivity molecular biology applications.
-
ARCA Cy3 EGFP mRNA (5-moUTP): Assay Reliability and Immune M
2026-05-01
Explore how ARCA Cy3 EGFP mRNA (5-moUTP) advances assay reproducibility and innate immune suppression in mRNA transfection. This article uniquely analyzes mechanistic insights and real-world protocol considerations for optimizing 5-methoxyuridine modified mRNA use.
-
AR Heterogeneity and BCL-2 Targeting in Castration-Resistant
2026-05-01
This study defines how androgen receptor (AR) expression heterogeneity in prostate cancer underpins distinct biological properties and therapeutic responses, particularly to castration and enzalutamide. Critically, it establishes BCL-2 as a therapeutic vulnerability in AR−/lo prostate cancer, suggesting new combinatorial treatment strategies.
-
Direct Mouse Genotyping Kit: Redefining High-Throughput Gene
2026-04-30
Explore how the Direct Mouse Genotyping Kit transforms mouse genomic DNA analysis by enabling PCR amplification directly from tissue lysates. This in-depth article reveals unique mechanistic insights, protocol optimization, and translational relevance for biomedical research.
-
Lyso-Tracker Red: Precision Lysosome Tracking in Cancer Rese
2026-04-30
Discover how Lyso-Tracker Red enables high-specificity lysosome labeling in live cells, supporting advanced research into lysosome-driven cell death and therapeutic innovation. This article uniquely bridges mechanistic insights from recent RCC studies with practical assay optimization.
-
Cy5 NHS ester(Et): Technical Guidance for Biomolecule Labeli
2026-04-29
Cy5 NHS ester(Et) enables efficient, water-soluble fluorescent labeling of primary amines in proteins and other biomolecules for detection and imaging workflows. It is not suitable for ethanol-based protocols or long-term storage of working solutions. Researchers should adhere to recommended dissolution and handling procedures to ensure reliable results.
-
GOB-38 β-Lactamase in E. anophelis: Biochemical Specificity
2026-04-29
This study characterizes the biochemical properties and substrate specificity of the newly identified GOB-38 metallo-β-lactamase from Elizabethkingia anophelis, highlighting its broad-spectrum antibiotic hydrolysis and unique active site features. The findings have important implications for carbapenem resistance and horizontal gene transfer in hospital pathogens.
-
Annexin V-Cy5/DAPI Apoptosis Kit: Accelerated Cell Death Ana
2026-04-28
The Annexin V-Cy5/DAPI Apoptosis Kit streamlines early and late apoptosis detection with rapid, dual-parameter sensitivity. Its robust workflow and phosphatidylserine binding specificity make it indispensable for mechanistic studies in oncology, including translational research on apoptosis pathways.
-
IGFBP2-THBS1 Axis in GH-Induced Bone Growth in ISS Children
2026-04-28
This study elucidates how recombinant human growth hormone (GH) therapy promotes bone growth in idiopathic short stature (ISS) children by activating the IGF-1 pathway via IGFBP2-mediated inhibition of THBS1. The findings reveal IGFBP2 as a critical mediator in chondrocyte proliferation and differentiation, providing new mechanistic insight and potential therapeutic targets for optimizing GH interventions in pediatric growth disorders.